• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

症状性乳房诊所的敏感性和漏诊率:一项回顾性队列研究,纳入 40323 例患者。

Sensitivity and missed cancer rate in the symptomatic breast clinic-A retrospective cohort study of 40 323 patients.

机构信息

Bristol Breast Care Centre, North Bristol NHS Trust, Southmead Hospital, Westbury-On-Trym, UK.

出版信息

Breast J. 2021 Mar;27(3):248-251. doi: 10.1111/tbj.14134. Epub 2020 Dec 26.

DOI:10.1111/tbj.14134
PMID:33368778
Abstract

INTRODUCTION

Symptomatic presentations account for the majority of invasive breast cancer diagnoses. While the National Health Service Breast Screening Programme is subjected to strict quality control, no such system for performance monitoring exists in the symptomatic clinic. We assess the sensitivity of cancer detection and missed cancer rate for symptomatic breast patients to benchmark future outcome measures.

METHODS

A retrospective cohort study of patients attending the symptomatic breast clinic between October 2013 and October 2018 was performed. Patients with new cancer diagnoses were identified and screened for those who had presented to the department within the 3 years prior to their diagnosis. From this, the sensitivity and missed cancer rate were calculated.

RESULTS

About 40 323 patients were seen over the 5-year study period. About 2155 new cancers were diagnosed, with 2033 identified at their initial clinic attendance. A further 122 patients had cancer diagnosed on a subsequent appointment, of which 23 patients were considered to have had a delay in diagnosis. The sensitivity of the one-stop symptomatic breast clinic was therefore 99.0%, and the missed cancer rate was 0.06% over 5 years.

CONCLUSION

The missed cancer rate reported in this study is favorable compared to the outcomes reported in the National Health Service Breast Screening Programme and superior to the only other study reporting outcomes on a much smaller cohort. The unit in question therefore is performing exceptionally against current standards and sets a benchmark against which future performance can be measured.

摘要

简介

有症状的表现占了大多数浸润性乳腺癌的诊断。虽然国民保健制度乳房筛查计划受到严格的质量控制,但在有症状的诊所中并没有这样的绩效监测系统。我们评估了癌症检测的敏感性和漏诊癌症率,以便为未来的结果衡量指标提供基准。

方法

对 2013 年 10 月至 2018 年 10 月期间在有症状的乳房诊所就诊的患者进行了回顾性队列研究。对新诊断癌症的患者进行了识别,并对在诊断前 3 年内到科室就诊的患者进行了筛查。由此计算了敏感性和漏诊癌症率。

结果

在 5 年的研究期间,大约有 40323 名患者就诊。约有 2155 例新癌症被诊断出,其中 2033 例在初次就诊时被发现。另有 122 例患者在随后的就诊中被诊断出癌症,其中 23 例被认为有诊断延误。因此,一站式有症状乳房诊所的敏感性为 99.0%,5 年内的漏诊癌症率为 0.06%。

结论

与国民保健制度乳房筛查计划报告的结果相比,本研究报告的漏诊癌症率是有利的,并且优于仅对规模小得多的队列报告结果的另一项研究。因此,有问题的单位在当前标准下表现出色,为未来的绩效提供了衡量基准。

相似文献

1
Sensitivity and missed cancer rate in the symptomatic breast clinic-A retrospective cohort study of 40 323 patients.症状性乳房诊所的敏感性和漏诊率:一项回顾性队列研究,纳入 40323 例患者。
Breast J. 2021 Mar;27(3):248-251. doi: 10.1111/tbj.14134. Epub 2020 Dec 26.
2
Minority report - false negative breast assessment in women recalled for suspicious screening mammography: imaging and pathological features, and associated delay in diagnosis.少数病例报告——因乳腺钼靶筛查可疑而被召回的女性中乳腺评估假阴性:影像学和病理特征以及相关诊断延迟
Breast Cancer Res Treat. 2007 Sep;105(1):37-43. doi: 10.1007/s10549-006-9425-3. Epub 2006 Nov 18.
3
Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.1991年4月至1997年3月哥本哈根乳腺癌的乳腺X线筛查。乳腺X线筛查评估小组。
APMIS Suppl. 1998;83:1-44.
4
Breast screening in symptomatic women over 35 years of age: improvements in service efficiency.35岁以上有症状女性的乳腺筛查:服务效率的提高
Ir J Med Sci. 2019 Feb;188(1):55-58. doi: 10.1007/s11845-018-1794-1. Epub 2018 Mar 26.
5
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic.对1110名前往有症状乳腺门诊就诊患者进行“一站式”诊断的准确性。
J R Coll Surg Edinb. 1999 Aug;44(4):226-30.
6
Will adherence to new guidance lead to missed cancer diagnoses? Evaluation of limiting symptomatic mammograms to over forties.新指南的坚持是否会导致癌症漏诊?评估将症状性乳房 X 光检查限于 40 岁以上人群。
Breast J. 2013 Mar-Apr;19(2):142-8. doi: 10.1111/tbj.12074. Epub 2013 Jan 14.
7
A comparison of clinical-pathological characteristics between symptomatic and interval breast cancer.有症状乳腺癌与间期乳腺癌临床病理特征的比较。
Breast. 2015 Jun;24(3):278-82. doi: 10.1016/j.breast.2015.02.032. Epub 2015 Mar 11.
8
Breast cancers missed during screening in a tertiary-care hospital mammography facility.在一家三级医疗医院的乳腺钼靶检查机构中,筛查时漏诊的乳腺癌。
Ann Saudi Med. 2019 Jul-Aug;39(4):236-243. doi: 10.5144/0256-4947.2019.236. Epub 2019 Aug 5.
9
Effectiveness of Digital Breast Tomosynthesis Compared With Digital Mammography: Outcomes Analysis From 3 Years of Breast Cancer Screening.数字乳腺断层合成摄影与数字乳腺钼靶摄影的有效性比较:3 年乳腺癌筛查的结果分析。
JAMA Oncol. 2016 Jun 1;2(6):737-43. doi: 10.1001/jamaoncol.2015.5536.
10
Mammography screening in the county of Fyn. November 1993-December 1999.菲英岛县的乳腺钼靶筛查。1993年11月 - 1999年12月。
APMIS Suppl. 2003(110):1-33.

引用本文的文献

1
The association of breast surgery ASPIRE: breast pain pathway rapid evaluation project - study protocol.乳房手术ASPIRE协会:乳房疼痛途径快速评估项目——研究方案。
Int J Surg Protoc. 2024 Feb 15;28(1):37-42. doi: 10.1097/SP9.0000000000000021. eCollection 2024 Mar.
2
Evaluating a novel patient pathway to manage symptomatic breast referrals (the blue flag clinic): a longitudinal observational study.评估一种管理有症状乳腺转诊患者的新型路径(蓝旗诊所):一项纵向观察性研究。
Ann R Coll Surg Engl. 2025 Jul;107(6):397-402. doi: 10.1308/rcsann.2023.0028. Epub 2023 Jul 25.
3
Considerations for Evaluating the Introduction of New Cancer Screening Technology: Use of Interval Cancers to Assess Potential Benefits and Harms.
评估新癌症筛查技术引入的考虑因素:利用间期癌评估潜在获益和危害。
Int J Environ Res Public Health. 2022 Nov 8;19(22):14647. doi: 10.3390/ijerph192214647.